The Albert Einstein Cancer Center is led by the Director, Deputy Director and seven Associate Directors. Since the last renewal. Dr. Roman Perez-Soler was appointed Deputy Director and Dr. Joseph Sparano was appointed Associate Director for Clinical Research. In addition, Dr. Steven Libutti was appointed Associate Director for Clinical Services (no CCSG support requested). The current full roster of senior leadership includes the Director of the Center (I. David Goldman, MD), Deputy Director (Roman Perez-Soler, MD), Associate Director for Laboratory Research (Pamela Stanley, PhD), Associate Director for Clinical Research (Joseph Sparano, MD), Associate Director for Therapeutics (Susan Horwitz, PhD), Associate Director for Population Sciences (Thomas Rohan, MD, PhD), Associate Director for Administration (Richard Seither, PhD, MBA), Associate Director for Shared Resources (Michael Prystowsky, MD, PhD), and Associate Director for Clin cal Services (Steven Libutti, MD).

Public Health Relevance

Cancer Center Senior Leadership supports the translational research mission and goals of the Albert Einstein Cancer Center (AECC). As an NCI-designated Cancer Center, AECC contributes to the national effort to reduce morbidity and mortality from cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013330-42
Application #
8885666
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
2015-08-31
Budget Start
2015-07-01
Budget End
2016-06-30
Support Year
42
Fiscal Year
2015
Total Cost
$115,653
Indirect Cost
$57,397
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Hayama, Ryo; Sparks, Samuel; Hecht, Lee M et al. (2018) Thermodynamic characterization of the multivalent interactions underlying rapid and selective translocation through the nuclear pore complex. J Biol Chem 293:4555-4563
Willis, Ian M; Moir, Robyn D; Hernandez, Nouria (2018) Metabolic programming a lean phenotype by deregulation of RNA polymerase III. Proc Natl Acad Sci U S A 115:12182-12187
Martynova, Elena; Bouchard, Maxime; Musil, Linda S et al. (2018) Identification of Novel Gata3 Distal Enhancers Active in Mouse Embryonic Lens. Dev Dyn 247:1186-1198
Huang, Kezhen; Mukherjee, Subhajit; DesMarais, Vera et al. (2018) Targeting the PXR-TLR4 signaling pathway to reduce intestinal inflammation in an experimental model of necrotizing enterocolitis. Pediatr Res 83:1031-1040
Bines, Jose; Tevaarwerk, Amye J (2018) Baby steps: Pregnancy outcomes after human epidermal growth factor receptor 2-targeted therapy. Cancer :
Mathew, Deepti; Wang, Yanhua; Van Arsdale, Anne et al. (2018) Expression of ?V-Tubulin in Secretory Cells of the Fallopian Tube Epithelium Marks Cellular Atypia. Int J Gynecol Cancer 28:363-370
Mao, Kai; Quipildor, Gabriela Farias; Tabrizian, Tahmineh et al. (2018) Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nat Commun 9:2394
Entenberg, David; Voiculescu, Sonia; Guo, Peng et al. (2018) A permanent window for the murine lung enables high-resolution imaging of cancer metastasis. Nat Methods 15:73-80
Iqbal, Niloy Jafar; Lu, Zhonglei; Liu, Shun Mei et al. (2018) Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity. JCI Insight 3:
Sharma, Yogeshwar; Liu, Jinghua; Kristian, Kathleen E et al. (2018) In Atp7b-/- Mice Modeling Wilson's Disease Liver Repopulation with Bone Marrowderived Myofibroblasts or Inflammatory Cells and not Hepatocytes is Deleterious. Gene Expr :

Showing the most recent 10 out of 1508 publications